Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability

Detalhes bibliográficos
Autor(a) principal: Fagundes, Gabriela E.
Data de Publicação: 2019
Outros Autores: Macan, Tamires P., Rohr, Paula, Damiani, Adriani P., Rodrigues da Rocha, Franciani, Pereira, Maiara, Longaretti, Luiza M., Vilela, Thais C., Ceretta, Luciane B., Mendes, Carolini, Silveira, Paulo C.L., Teixeira, João Paulo F., Moraes de Andrade, Vanessa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.18/6574
Resumo: Erratum in - Corrigendum: Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability. Fagundes GE, Macan TP, Rohr P, Damiani AP, Da Rocha FR, Pereira M, Longaretti LM, Vilela TC, Ceretta LB, Mendes C, Silveira PCL, Teixeira JPF, de Andrade VM. Mutagenesis. 2019 May 29;34(2):215. doi: 10.1093/mutage/gez006.
id RCAP_100e957ba118f6d67fdf1e18e9571108
oai_identifier_str oai:repositorio.insa.pt:10400.18/6574
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instabilityDiabetes MellitusType 2 Diabetes MellitusVitamin D3Erratum in - Corrigendum: Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability. Fagundes GE, Macan TP, Rohr P, Damiani AP, Da Rocha FR, Pereira M, Longaretti LM, Vilela TC, Ceretta LB, Mendes C, Silveira PCL, Teixeira JPF, de Andrade VM. Mutagenesis. 2019 May 29;34(2):215. doi: 10.1093/mutage/gez006.Type 2 diabetes mellitus has undergone a worldwide growth in incidence in the world and has now acquired epidemic status. There is a strong link between type 2 diabetes and vitamin D deficiency. Because vitamin D has beneficial effects on glucose homeostasis, the aim of this study was to evaluate the influence of vitamin D3 supplementation on the modulation of glycaemic control and other metabolic effects, as well as modulation of genomic instability in patients with type 2 diabetes. We evaluated 75 patients with type 2 diabetes, registered in the Integrated Clinics of the University of Southern Santa Catarina. Participants received 4000 IU of vitamin D3 (25(OH)D) supplementation daily for 8 weeks. Blood samples were collected at the beginning and at the end of the supplementation, and 4 weeks after the end of supplementation. The glycidic and lipid profiles [total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein and triglycerides], oxidative stress, DNA damage and 25(OH)D levels were evaluated. Vitamin D3 supplementation for 8 weeks showed enough to significantly increase blood levels of 25(OH)D. A significant difference in lipid profile was observed only in non-HDL cholesterol. Significant changes were observed in glucose homeostasis (fasting glucose and serum insulin) and, in addition, a reduction in the parameters of oxidative stress and DNA damage. There was a significant reduction in the values of 25(OH)D 4 weeks after the end of the supplementation, but levels still remained above baseline. Use of vitamin D supplementation can be an ally in the health modulation of patients with type 2 diabetes mellitusThis work was supported by grants from Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina (FAPESC) and Programa de Pós-Graduação em Ciências da Saúde/ Universidade do Extremo Sul Catarinense.Oxford University Press/ United Kingdom Environmental Mutagen SocietyRepositório Científico do Instituto Nacional de SaúdeFagundes, Gabriela E.Macan, Tamires P.Rohr, PaulaDamiani, Adriani P.Rodrigues da Rocha, FrancianiPereira, MaiaraLongaretti, Luiza M.Vilela, Thais C.Ceretta, Luciane B.Mendes, CaroliniSilveira, Paulo C.L.Teixeira, João Paulo F.Moraes de Andrade, Vanessa2020-05-02T15:28:57Z2019-05-292019-05-29T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfhttp://hdl.handle.net/10400.18/6574engMutagenesis. 2019 May 29;34(2):135-145. doi: 10.1093/mutage/gez0010267-835710.1093/mutage/gez001info:eu-repo/semantics/embargoedAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:41:15Zoai:repositorio.insa.pt:10400.18/6574Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:40:48.953047Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
title Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
spellingShingle Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
Fagundes, Gabriela E.
Diabetes Mellitus
Type 2 Diabetes Mellitus
Vitamin D3
title_short Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
title_full Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
title_fullStr Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
title_full_unstemmed Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
title_sort Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability
author Fagundes, Gabriela E.
author_facet Fagundes, Gabriela E.
Macan, Tamires P.
Rohr, Paula
Damiani, Adriani P.
Rodrigues da Rocha, Franciani
Pereira, Maiara
Longaretti, Luiza M.
Vilela, Thais C.
Ceretta, Luciane B.
Mendes, Carolini
Silveira, Paulo C.L.
Teixeira, João Paulo F.
Moraes de Andrade, Vanessa
author_role author
author2 Macan, Tamires P.
Rohr, Paula
Damiani, Adriani P.
Rodrigues da Rocha, Franciani
Pereira, Maiara
Longaretti, Luiza M.
Vilela, Thais C.
Ceretta, Luciane B.
Mendes, Carolini
Silveira, Paulo C.L.
Teixeira, João Paulo F.
Moraes de Andrade, Vanessa
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Nacional de Saúde
dc.contributor.author.fl_str_mv Fagundes, Gabriela E.
Macan, Tamires P.
Rohr, Paula
Damiani, Adriani P.
Rodrigues da Rocha, Franciani
Pereira, Maiara
Longaretti, Luiza M.
Vilela, Thais C.
Ceretta, Luciane B.
Mendes, Carolini
Silveira, Paulo C.L.
Teixeira, João Paulo F.
Moraes de Andrade, Vanessa
dc.subject.por.fl_str_mv Diabetes Mellitus
Type 2 Diabetes Mellitus
Vitamin D3
topic Diabetes Mellitus
Type 2 Diabetes Mellitus
Vitamin D3
description Erratum in - Corrigendum: Vitamin D3 as adjuvant in the treatment of type 2 diabetes mellitus: modulation of genomic and biochemical instability. Fagundes GE, Macan TP, Rohr P, Damiani AP, Da Rocha FR, Pereira M, Longaretti LM, Vilela TC, Ceretta LB, Mendes C, Silveira PCL, Teixeira JPF, de Andrade VM. Mutagenesis. 2019 May 29;34(2):215. doi: 10.1093/mutage/gez006.
publishDate 2019
dc.date.none.fl_str_mv 2019-05-29
2019-05-29T00:00:00Z
2020-05-02T15:28:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.18/6574
url http://hdl.handle.net/10400.18/6574
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Mutagenesis. 2019 May 29;34(2):135-145. doi: 10.1093/mutage/gez001
0267-8357
10.1093/mutage/gez001
dc.rights.driver.fl_str_mv info:eu-repo/semantics/embargoedAccess
eu_rights_str_mv embargoedAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Oxford University Press/ United Kingdom Environmental Mutagen Society
publisher.none.fl_str_mv Oxford University Press/ United Kingdom Environmental Mutagen Society
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132150846455808